| dbo:abstract
|
- Tripelennamin (Handelsname: Azaron®) ist ein Arzneistoff der ersten Generation von Antihistaminika.Es wird zur Behandlung von Juckreiz nach Insektenstichen und allergischen Hautreaktionen verwendet. (de)
- La tripelennamina è un principio attivo, fa parte del gruppo degli antagonisti dei recettori H di prima generazione insieme alla clorciclizina, difenidramina, mepiramina, prometazina, e altri. Venne scoperta da Carl Djerassi (it)
- Tripelennamine, sold under the brand name Pyribenzamine by Novartis, is a drug that is used as an antipruritic and first-generation antihistamine. It can be used in the treatment of asthma, hay fever, rhinitis, and urticaria, but is now less common as it has been replaced by newer antihistamines. The drug was patented at CIBA, which merged with Geigy into Ciba-Geigy, and eventually becoming Novartis. (en)
- Tripelennamine of pyribenzamine is een eerste generatie pyridine en antihistaminicum uit de ethyleendiamineklasse. Het wordt toegepast bij de behandeling van astma, hooikoorts, rinitis en urticaria, maar raakt buiten gebruik vanwege vervanging door nieuwere antihistamines. (nl)
|
| dbo:alternativeName
| |
| dbo:casNumber
|
- (hydrochloride)
- (maleate)
- (citrate)
- (monohydrochloride)
- 91-81-6
|
| dbo:chEMBL
| |
| dbo:drugbank
| |
| dbo:fdaUniiCode
| |
| dbo:kegg
| |
| dbo:medlinePlus
| |
| dbo:pubchem
| |
| dbo:thumbnail
| |
| dbo:wikiPageID
| |
| dbo:wikiPageLength
|
- 7866 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID
| |
| dbo:wikiPageWikiLink
| |
| dbp:atcPrefix
| |
| dbp:atcSuffix
| |
| dbp:c
| |
| dbp:casNumber
| |
| dbp:chembl
| |
| dbp:chemspiderid
| |
| dbp:drugbank
| |
| dbp:eliminationHalfLife
| |
| dbp:excretion
| |
| dbp:h
| |
| dbp:image
|
- Tripelennaminefinal.png (en)
|
| dbp:iupacName
|
- N,N-dimethyl-N--N-pyridin-2-ylethane-1,2-diamine (en)
|
| dbp:iupharLigand
| |
| dbp:kegg
| |
| dbp:legalStatus
| |
| dbp:medlineplus
| |
| dbp:metabolism
|
- Hepatic hydroxylation and glucuronidation (en)
|
| dbp:n
| |
| dbp:pubchem
| |
| dbp:routesOfAdministration
| |
| dbp:smiles
| |
| dbp:stdinchi
| |
| dbp:stdinchikey
|
- UFLGIAIHIAPJJC-UHFFFAOYSA-N (en)
|
| dbp:tradename
| |
| dbp:unii
| |
| dbp:verifiedrevid
| |
| dbp:watchedfields
| |
| dbp:wikiPageUsesTemplate
| |
| dcterms:subject
| |
| gold:hypernym
| |
| rdf:type
| |
| rdfs:comment
|
- Tripelennamin (Handelsname: Azaron®) ist ein Arzneistoff der ersten Generation von Antihistaminika.Es wird zur Behandlung von Juckreiz nach Insektenstichen und allergischen Hautreaktionen verwendet. (de)
- La tripelennamina è un principio attivo, fa parte del gruppo degli antagonisti dei recettori H di prima generazione insieme alla clorciclizina, difenidramina, mepiramina, prometazina, e altri. Venne scoperta da Carl Djerassi (it)
- Tripelennamine, sold under the brand name Pyribenzamine by Novartis, is a drug that is used as an antipruritic and first-generation antihistamine. It can be used in the treatment of asthma, hay fever, rhinitis, and urticaria, but is now less common as it has been replaced by newer antihistamines. The drug was patented at CIBA, which merged with Geigy into Ciba-Geigy, and eventually becoming Novartis. (en)
- Tripelennamine of pyribenzamine is een eerste generatie pyridine en antihistaminicum uit de ethyleendiamineklasse. Het wordt toegepast bij de behandeling van astma, hooikoorts, rinitis en urticaria, maar raakt buiten gebruik vanwege vervanging door nieuwere antihistamines. (nl)
|
| rdfs:label
|
- Tripelennamin (de)
- Tripelennamina (it)
- Tripelennamine (nl)
- Tripelennamine (en)
|
| owl:sameAs
| |
| prov:wasDerivedFrom
| |
| foaf:depiction
| |
| foaf:isPrimaryTopicOf
| |
| is dbo:wikiPageRedirects
of | |
| is dbo:wikiPageWikiLink
of | |
| is foaf:primaryTopic
of | |